Skip to main content

Table 1 Clinical variables and demographic data from septic patients

From: Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis

  Control (n = 23) Sepsis (n = 27) Survival (n = 8) Non-survival (n = 19) P valuea S × NS
Demographic data      
Age, mean ± SD, year 65 ± 14.6 62.4 ± 12.8 60 ± 15.8 63.4 ± 11.6 0.5357
Sex (% of male) 60.9 70.4 87.5 63.2 0.3645
Place of acquired infection (%)      
 Prior to ICU NA 77.8 87.5 73.68 0.6334
 ICU acquired NA 22.2 12.5 26.32  
Severity of disease      
Septic shock (%) NA 77.8 87.5 73.68 0.6334
Severity scores, mean ± SD      
 Apache II NA 17.1 ± 6.5 15.6 ± 7.6 17.7 ± 6 0.4483
 SOFA NA 8.3 ± 2.9 8.0 ± 2.9 8.4 ± 2.9 0.7709
 Delta-SOFA (D3-D0) NA (−) 0.4 ± 3.1 (−) 1.9 ± 3.4 0.7 ± 2.8 0.0666
Organ dysfunction (%)      
 Cardiovascular NA 88.9 87.5 89.5 1
 Renal NA 37 37.5 36.8 1
 Respiratory NA 85.2 75 89.5 0.5583
 Hematological NA 11.1 0 15.8 0.5323
 Hepatological NA 33.3 25 36.8 0.6758
 Central nervous system NA 44.4 50 42 1
Underlying conditions      
Chronic comorbidity (%)      
 AIDS NA 0 0 0
 COPD NA 15.4 12.5 16.7 1
 Diabetes NA 30.8 12.5 38.9 0.3602
 Chronic renal disease NA 7.7 0 11.1 1
 Cardiovascular insufficiency NA 11.5 0 16.7 0.5292
Drugs (%)      
 Corticosteroids NA 37 50 31.6 0.4147
  1. S survivor, NS non-survivor, NA not applicable, SOFA Sequential [Sepsis-related] Organ Failure Assessment, COPD chronic obstructive pulmonary disease
  2. aFisher’s exact test or unpaired t-test were applied to determine the P value when comparing survival and non-survival groups